Skip to content
Pateclizumab
Pateclizumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against lymphotoxin-alpha.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
2 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Rheumatoid arthritisD001172EFO_0000685M06.911———2
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePATECLIZUMAB
INNpateclizumab
Description
Pateclizumab (humanized mab)
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID1202526-59-7
RxCUI—
ChEMBL IDCHEMBL1743056
ChEBI ID—
PubChem CID—
DrugBankDB14997
UNII IDQOK1YYH7J2 (ChemIDplus, GSRS)
Target
Agency Approved
LTA
LTA
Organism
Homo sapiens
Gene name
LTA
Gene synonyms
TNFB, TNFSF1
NCBI Gene ID
4049
Protein name
lymphotoxin-alpha
Protein synonyms
LT-alpha, TNF superfamily, member 1, TNF-beta, tumor necrosis factor beta, tumor necrosis factor ligand 1E, Tumor necrosis factor ligand superfamily member 1
Uniprot ID
Q9UKS8
Mouse ortholog
Lta (16992)
lymphotoxin-alpha (P09225)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 31 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
2 adverse events reported
View more details